Comparison of the outcomes of patients with primary central nervous system lymphoma between the neurosurgery and hematology/oncology departments based on the relative dose intensity of methotrexate.
Autorzy:
Hosoi H; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Okamura T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Fukai J; Department of Neurological Surgery, Wakayama Medical University, Wakayama 641-8509, Japan. Hori Y; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Murata S; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Mushino T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Nakao N; Department of Neurological Surgery, Wakayama Medical University, Wakayama 641-8509, Japan. SonokiT; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan.
Pokaż więcej
Źródło:
Oncology letters [Oncol Lett] 2023 Sep 19; Vol. 26 (5), pp. 469. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
Allosteric Inhibition of c-Abl to Induce Unfolded Protein Response and Cell Death in Multiple Myeloma.
Autorzy:
Kosako H; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Yamashita Y; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Morita S; The First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan. Iwabuchi S; Department of Molecular Pathophysiology, Wakayama Medical University, Wakayama 641-8509, Japan. Hashimoto S; Department of Molecular Pathophysiology, Wakayama Medical University, Wakayama 641-8509, Japan. Matsuoka TA; The First Department of Internal Medicine, Wakayama Medical University, Wakayama 641-8509, Japan. SonokiT; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan. Tamura S; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 641-8509, Japan.; Department of Emergency and Intensive Care Medicine, Wakayama Medical University, Wakayama 641-8509, Japan.
Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome.
Autorzy:
Sakaki A; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan. Hosoi H; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.; Department of Internal Medicine, Kainan Municipal Medical Center, Wakayama, Japan. Kosako H; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan. Furuya Y; Department of Internal Medicine, Kainan Municipal Medical Center, Wakayama, Japan. Iwamoto R; Department of Human Pathology, Wakayama Medical University, Wakayama, Japan. Hiroi T; Department of Internal Medicine, Kainan Municipal Medical Center, Wakayama, Japan. Murata S; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan. Mushino T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan. Murata SI; Department of Human Pathology, Wakayama Medical University, Wakayama, Japan. SonokiT; Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Oct; Vol. 63 (10), pp. 2499-2502. Date of Electronic Publication: 2022 May 13.
Sudden Cardiac Death in a Patient with Thrombotic Thrombocytopenic Purpura: A Case Report.
Autorzy:
Yoshida K; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Murata S; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Morimoto M; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Mushino T; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Tanaka K; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Yamashita Y; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Hosoi H; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Nishikawa A; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Tamura S; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan. Hatakeyama K; Department of Pathology, National Cerebral and Cardiovascular Center, Osaka 5648565, Japan. Matsumoto M; Department of Blood Transfusion Medicine, Nara Medical University, Nara 6348521, Japan. SonokiT; Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan.
Pokaż więcej
Źródło:
Hematology reports [Hematol Rep] 2022 Jun 02; Vol. 14 (2), pp. 203-209. Date of Electronic Publication: 2022 Jun 02.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
